Correlation between Acute Physiology and Chronic Health Evaluation (APACHE) III score and immunological parameters in critically ill patients with sepsis

British Journal of Surgery

Volumn 83, Issue 3, 1996, Pages 396-400

  Rogy, M A ^a   Oldenburg, H S A ^a   Coyle, S ^a   Trousdale, R ^a   Moldawer, L L ^a   Lowry, S F ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LIPOPOLYSACCHARIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; ETIOLOGY; FEMALE; HUMAN; IMMUNITY; IN VITRO STUDY; MALE; MONOCYTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; SEPSIS; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; APACHE; CHRONIC DISEASE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTENSIVE CARE; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; SHOCK, SEPTIC; SURVIVAL RATE;

EID: 0029974637     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800830333     Document Type: Article

References (43)

1. Wasson JH, Sox HC, Neff RK, Goldman L. Clinical prediction rules. Application and methodological standards. N Engl J Med 1985; 313: 793-9.
2. Silverstein MD. Prediction instruments and clinical judgement in critical care. JAMA 1988; 260: 1758-9 (Editorial).
3. Seneff M, Knaus WA. Predicting patients outcome from intensive care: a guide to APACHE, MPM, SAPS, PRISM and other prognostic scoring systems. J Intensive Care Med 1990; 5: 33-52.
4. Schulz F, Függer R, Herbst F, Rogy MA. The prognostic value of the Manheim peritonitis index at another institution. Surg Res Comm 1988; 3(Suppl 1): 39 (Abstract).
5. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. Prognosis in acute organ-system failure. Ann Surg 1985; 202: 685-93.
6. Marik PE. Gastric intramucosal pH. A better predictor of multiorgan dysfunction syndrome and death than oxygen-derived variables in patients with sepsis. Chest 1993; 104: 225-9.
7. Bakker J, Coffernils M, Leon M, Gris P, Vincent JL. Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock. Chest 1991; 99: 956-62.
8. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: severity of disease classification system. Crit Care Med 1985; 13: 818-29.
9. Brown PE, McClave S, Hoy NW, Short AF, Sexton KL, Meyer KL. The Acute Physiology and Chronic Health Evaluation II classification system is a valid marker for physiologic stress in the critically ill patient. Crit Care Med 1993; 21: 363-7.
10. Cerra FB, Negro F, Abrams J. APACHE II score does not predict multiple organ failure or mortality in postoperative surgical patients. Arch Surg 1990; 125: 519-22.
11. Rogy M, Fug̈ger R, Schemper M, Koss G, Schulz F. The value of two distinct prognosis scores in patients with peritonitis. The Manheim Peritonitis Index versus APACHE II score. Chirurg 1990; 61: 297-300.
12. Knaus WA, Wagner DP, Draper EA et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100: 1619-36.
13. Knaus WA, Wagner DP, Lynn J. Short term mortality predictions for critically ill hospitalized adults: science and ethics. Science 1991; 254: 389-94.
14. Rogy MA, Coyle SM, Oldenburg HSA et al. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients. J Am Coll Surg 1994; 178: 132-8.
15. Tracey KJ, Lowry SF, Fahey TJ III et al. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecot Obstet 1987; 164: 415-22.
16. Damas P, Ledoux D, Nys M et al. Cytokine serum level during severe sepsis in human IL-6 as marker of severity. Ann Surg 1992; 215: 356-62.
17. Sullivan JS, Kilpatrick L, Costarino AT Jr, Lee SC, Harris MC. Correlation of plasma cytokine elevations with mortality rate in children with sepsis. J Pediatr 1992; 120: 510-15.
18. Calandra T, Gerain J, Heumann D, Baumgartner JD, Glauser MP. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group. Am J Med 1991; 91: 23-9.
19. Munoz C, Carlet J, Fitting C, Misset B, Bleriot JP, Cavaillon JM. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 1991; 88: 1747-54.
20. Fasano MB, Cousart S, Neal S, McCall CE. Increased expression of the interleukin-1 receptor on blood neutrophils of humans with the sepsis syndrome. J Clin Invest 1991; 88: 1452-9.
21. Munoz C, Misset B, Fitting C, Bleriot JP, Carlet J, Cavaillon JM. Dissociation between plasma and monocyte-associated cytokines during sepsis. Eur J Immunol 1991; 21: 2177-84.
22. Hershman MJ, Appel SH, Wellhausen SR, Sonnenfeld G, Polk HC Jr. Interferon-gamma treatment increases HLA-DR expression on monocytes in severely injured patients. Clin Exp Immunol 1989; 77: 67-70.
23. Granowitz EV, Porat R, Mier JW et al. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J Immunol 1993; 151: 1637-45.
24. 2 production by trauma patients' monocytes. Arch Surg 1990; 125: 29-35.
25. Smith DM, Lackides GA, Epstein LB. Coordinated induction of autocrine tumor necrosis factor and interleukin-1 in normal human monocytes and the implications for monocyte-mediated cytotoxicity. Cancer Res 1990; 50: 3146-53.
26. Ziegler JE, Fisher CJ Jr, Sprung CL et al. Treatment of Gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. New Engl J Med 1991; 324: 429-36.
27. Endres S, Ghorbani R, Lonneman G, van der Meer JWM, Dinarello CA. Measurement of immunoreactive interleukin-1β from human mononuclear cells: optimization of recovery, intrasubject consistency, and comparison with interleukin-1α and tumor necrosis factor. Clin Immunol Immunopathol 1988; 49: 424-38.
28. Espevik T, Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1986; 95: 99-105.
29. Pollack MM, Ruttiman UE, Getson PR. Accurate prediction of the outcome of pediatric intensive care. A new quantitative method. N Engl J Med 1987; 316: 134-9.
30. Hebert PC, Drummond AJ, Singer J, Bernard GR, Russell JA. A simple multiple system organ failure scoring system predicts mortality of patients who have sepsis syndrome. Chest 1993; 104: 230-5.
31. Sanchez-Cantu L, Rode HN, Christou NV. Endotoxin tolerance is associated with reduced secretion of tumor necrosis factor. Arch Surg 1989; 124: 1432-6.
32. Mathison JC, Virca GD, Wolfson E, Tobias PS, Glaser K, Ulevitch RJ. Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages. J Clin invest 1990; 85: 1108-18.
33. Cavaillon JM, Fitting C, Haeffner-Cavaillon N, Kirsch JS, Warren HS. Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide. Infect Immun 1990; 58: 2375-82.
34. Zhong WW, Burke PA, Hand AT, Walsh MJ, Hughes LA, Forse RA. Regulation of cytokine mRNA expression in lipopolysaccharide-stimulated human macrophages. Arch Surg 1993; 128: 158-64.
35. Haas JG, Thiel C, Blömer K, Weiss EH, Riethmüller G, Ziegler-Heitbrock HW. Downregulation of tumor necrosis factor expression in the human Mono-Mac-6 cell line by lipopolysaccharide. J Leukoc Biol 1989; 46: 11-14.
36. Fenton MJ, Clark BD, Collins KL, Webb AC, Rich A, Auron PE. Transcriptional regulation of the human prointerleukin 1β gene. J Immunol 1987; 138: 3972-9.
37. Madonna GS, Vogel SN. Early endotoxin tolerance is associated with alterations in bone marrow-derived macrophage precursor pools. J Immunol 1985; 135: 3763-71.
38. Porteu F, Nathan C. Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med 1990; 172: 599-607.
39. Ding AH, Sanchez E, Srimal S, Nathan CF. Macrophages rapidly internalize their tumor necrosis factor receptors in response to bacterial lipopolysaccharide. J Biol Chem 1989; 264: 3924-9.
40. Barriere SL, Lowry SF. An overview of mortality risk prediction in sepsis. Crit Care Med 1995; 23: 376-93.
41. Hershman MJ, Cheadle WG, Wellhausen SR, Davidson PF, Polk HC Jr. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 1990; 77: 204-7.
42. Faist E, Kupper TS, Baker CC, Chaudry IH, Dwyer J, Baue AE. Depression of cellular immunity after major injury. Its association with posttraumatic complications and its reversal with immunomodulation. Arch Surg 1986; 121: 1000-5.
43. Faist E, Mewes A, Strasser T et al. Alteration of monocyte function following major injury. Arch Surg 1988; 123: 287-92.